AngioDynamics Operating Cycle from 2010 to 2026
| ANGO Stock | USD 10.56 0.50 4.97% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 255 | Current Value 232.58 | Quarterly Volatility 37.51631019 |
Check AngioDynamics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AngioDynamics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.1 M, Interest Expense of 1.7 M or Total Revenue of 249.7 M, as well as many indicators such as Price To Sales Ratio of 2.44, Dividend Yield of 0.0 or PTB Ratio of 2.16. AngioDynamics financial statements analysis is a perfect complement when working with AngioDynamics Valuation or Volatility modules.
AngioDynamics | Operating Cycle | Build AI portfolio with AngioDynamics Stock |
Evaluating AngioDynamics's Operating Cycle across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into AngioDynamics's fundamental strength.
Latest AngioDynamics' Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of AngioDynamics over the last few years. It is AngioDynamics' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AngioDynamics' overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
AngioDynamics Operating Cycle Regression Statistics
| Arithmetic Mean | 206.42 | |
| Geometric Mean | 203.45 | |
| Coefficient Of Variation | 18.17 | |
| Mean Deviation | 29.66 | |
| Median | 195.83 | |
| Standard Deviation | 37.52 | |
| Sample Variance | 1,407 | |
| Range | 137 | |
| R-Value | 0.02 | |
| Mean Square Error | 1,501 | |
| R-Squared | 0.0004 | |
| Significance | 0.94 | |
| Slope | 0.15 | |
| Total Sum of Squares | 22,520 |
AngioDynamics Operating Cycle History
About AngioDynamics Financial Statements
AngioDynamics investors utilize fundamental indicators, such as Operating Cycle, to predict how AngioDynamics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 255.00 | 232.58 |
Pair Trading with AngioDynamics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.Moving together with AngioDynamics Stock
| 0.68 | 2DR | Inspire Medical Systems Earnings Call This Week | PairCorr |
Moving against AngioDynamics Stock
| 0.55 | IMDX | Insight Molecular Symbol Change | PairCorr |
| 0.51 | 4DX | 4DMEDICAL | PairCorr |
| 0.47 | AMS | Advanced Medical Sol | PairCorr |
| 0.43 | QIPT | Quipt Home Medical Earnings Call This Week | PairCorr |
| 0.41 | TRLS | Trellus Health plc | PairCorr |
The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of AngioDynamics Correlation against competitors. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Will Health Care Equipment & Supplies sector continue expanding? Could AngioDynamics diversify its offerings? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AngioDynamics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.67) | Revenue Per Share | Quarterly Revenue Growth 0.09 | Return On Assets | Return On Equity |
Investors evaluate AngioDynamics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating AngioDynamics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause AngioDynamics' market price to deviate significantly from intrinsic value.
Understanding that AngioDynamics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AngioDynamics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, AngioDynamics' market price signifies the transaction level at which participants voluntarily complete trades.